Target intelligence / Profile preview

No specific endogenous RNA or protein

Molecular classification
Other
01

Overview

The designation "No specific endogenous RNA or protein" is used in pharmacological contexts to describe therapeutic agents that do not achieve their effect by binding to a specific biological macromolecule. Instead of interacting with a defined receptor or enzyme, these drugs typically work through direct chemical or physical processes (ChEMBL Database, 2024). For example, antacids like aluminum hydroxide neutralize hydrochloric acid in the stomach via a simple acid-base reaction, while osmotic diuretics like mannitol create a physical pressure gradient to move water (DrugBank Online, 2024). Other agents in this category include activated charcoal, which adsorbs toxins, and certain surfactants like simethicone that alter the surface tension of gas bubbles. Because these substances lack a specific protein target, they are often excluded from traditional high-throughput screening and structure-activity relationship (SAR) studies. This classification is vital for data curation in bioinformatics to distinguish between targeted drugs and those with non-specific modes of action (StatPearls, 2023). Furthermore, the safety profiles of these agents are often related to systemic physiological changes, such as electrolyte imbalances, rather than off-target protein binding.

Other names
Non-specific targetNon-molecular targetNo specific targetNon-specific mechanism
02

Mechanism of action

Chemical neutralization, osmotic gradient formation, physical adsorption, or non-specific membrane perturbation

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Electrolyte imbalanceInterference with the absorption of other medicationsSystemic pH alterationsOsmotic stress
06

Interacting drugs

Aluminum hydroxide

6 more in the full profile.

Beyond the preview

Go deeper on No specific endogenous RNA or protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No specific endogenous RNA or protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call